Please login to the form below

Not currently logged in
Email:
Password:

financial report

This page shows the latest financial report news and features for those working in and with pharma, biotech and healthcare.

First Humira biosimilars reach EU market

First Humira biosimilars reach EU market

Meanwhile, a fifth biosimilar called Cyltezo from Boehringer Ingelheim has been approved for sale but its launch has been held up by patent litigation with AbbVie, according to a Financial Times ... report. Lawsuits involving other biosimilar adalimumab

Latest news

More from news
Approximately 1 fully matching, plus 56 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    According to a Financial Times report, this deal comes only months after BD at an analyst briefing stated it was seeking to reduce its leverage to three times annual cash flow. ... the company and improve its financial results ready for Bain/Cinven’s

  • Pharma deals during September 2013 Pharma deals during September 2013

    As is customary this month's report focuses on deals with disclosed financial terms.

  • Pharma deals during August 2013 Pharma deals during August 2013

    As is customary this month's report focuses on deals with disclosed financial terms. ... A minor diversion. And finally deviating from our customary practice, a mention of a deal with undisclosed financial terms, namely the three year, preclinical

  • Country report: The healthcare market in South Korea Country report: The healthcare market in South Korea

    according to the JMAJ report 'The South Korean Health Care System', from 2009. ... 9. Bayer. 10 . Roche. Source: Invest Korea (each company's financial report [2008]); Daily Pharma News (April 7, 2008) Note: year-on-year basis.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics